Main Menu

FDA is the Real Reason that DEA Can’t Re-Schedule Cannabis

FDA is the Real Reason that DEA Can’t Re-Schedule Cannabis

There’s been a lot of media attention recently revolving around the Drug Enforcement Administration (DEA), which was rumored to be planning a monumental decision to deschedule cannabis from its Schedule 1 label. However, news broke on Wednesday night that the agency is still working on rescheduling cannabis, but for the time being, they cannot reschedule it. The DEA must get an official recommendation from the FDA about the evidence and studies related to the substance before it can reschedule anything.

The DEA sent out a press release this morning, stating that it has denied two petitions to reschedule cannabis. Before any rescheduling occurs, the DEA has requested that more scientific research be conducted. It also asked for “a scientific and medical evaluation and scheduling recommendation” from the Department of Health and Human Services (HHS), which was already administered by the Food and Drug Administration (FDA) and National Institute on Drug Abuse (NIDA).

FDA is the Real Reason that DEA Can’t Re-Schedule Cannabis






Comments are Closed